Clinical Trials on Multiple chemische Empfindlichkeit
Total 8558 results
-
North Bristol NHS TrustUniversity of Nottingham; Medical Research Council; University of Bristol; Bristol... and other collaboratorsUnknownProgressive Multiple SclerosisUnited Kingdom
-
Universitätsklinikum Hamburg-EppendorfDeutsche Multiple Sklerose Gesellschaft HamburgUnknown
-
MedDay Pharmaceuticals SAUnknown
-
University at BuffaloTeva Pharmaceuticals USACompleted
-
University of GlasgowNHS Ayrshire and Arran; AKMCompletedProgressive Multiple SclerosisUnited Kingdom
-
Genzyme, a Sanofi CompanyCompletedProgressive Multiple SclerosisGermany
-
Rigshospitalet, DenmarkCompletedProgressive Multiple SclerosisDenmark
-
Artielle ImmunoTherapeuticsUnknownMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-RemittingUnited States
-
Radboud University Medical CenterRecruiting
-
Julie RichardsonMcMaster UniversityCompletedAging | Mobility Limitation | Chronic Conditions, MultipleCanada
-
Assaf-Harofeh Medical CenterUnknownRemoval of Colors Tattoo (Multiple Colors)Israel
-
Novartis PharmaceuticalsCompletedMultiple Sclerosis | Relapsing Multiple Sclerosis | Advancing Multiple SclerosisUnited States, Puerto Rico
-
Jules Bordet InstituteRayzeBio, Inc.Not yet recruitingMultiple Myeloma in Relapse | Multiple Myeloma, Refractory | Multiple Myeloma ProgressionBelgium
-
Harpoon TherapeuticsActive, not recruitingMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma of BoneUnited States, France, Spain
-
Novartis PharmaceuticalsActive, not recruitingActive Secondary Progressive Multiple SclerosisItaly
-
Novartis PharmaceuticalsTerminatedSecondary Progressive Multiple Sclerosis With Inflammatory Disease ActivitySwitzerland
-
Western University, CanadaUnknownRespiratory Failure | Pain, Acute | Thoracic Injuries | Trauma Chest | Rib Fracture Multiple | Pain, ChestCanada
-
Kessler FoundationInternational Progressive MS AllianceCompletedMemory Impairment | Cognition - Other | Multiple Sclerosis, ProgressiveUnited States
-
Boston Scientific CorporationTerminatedRelapsing Remitting Multiple SclerosisSpain, Germany, Belgium, Poland, France, Russian Federation
-
Centre Hospitalier Régional d'OrléansNational Scientific Research CentreCompletedMultiple Sclerosis | Multiple Sclerosis, Acute RelapsingFrance
-
Glasgow Caledonian UniversityUnknown
-
VA Office of Research and DevelopmentCompleted
-
National Institute of Allergy and Infectious Diseases...CompletedPrimary Progressive Multiple SclerosisUnited States
-
Anders SvenningssonVästerbotten County Council, SwedenCompletedProgressive Multiple SclerosisSweden
-
Genentech, Inc.Completed
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing Remitting Multiple Sclerosis
-
National Multiple Sclerosis SocietyCompletedMultiple SclerosisUnited States
-
Masaryk Hospital Usti nad LabemUnknownTrauma, Multiple | Lactate Blood Increase
-
University of KansasFutures Without ViolenceUnknownDomestic Violence | Multiple Forms of Child AbuseUnited States
-
PfizerCompletedSafety | Pharmacokinetic | Phase 1 | Multiple Dose | TolerationBelgium
-
Assiut UniversityUnknown
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
University of Colorado, DenverNational Institute on Aging (NIA)CompletedChronic Conditions, MultipleUnited States
-
Weill Medical College of Cornell UniversityCompletedMultiple Chronic IllnessesUnited States
-
Novartis PharmaceuticalsCompletedMultiple Sclerosis, Relapsing Forms of Multiple SclerosisSpain, Canada, France, Switzerland, Italy, Portugal, Denmark, Poland, Germany, United Kingdom
-
Kyverna TherapeuticsNot yet recruitingMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary Progressive
-
University of UtahCompletedMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Secondary Progressive Multiple SclerosisUnited States
-
Mayo ClinicCompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Clinical Isolated Syndrome (CIS)Czech Republic, Switzerland
-
BiogenWithdrawnRelapsing-Remitting Multiple Sclerosis (RRMS)
-
National Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
National Cancer Institute (NCI)TerminatedStage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
AM-PharmaCompletedSepsis | Multiple Organ Dysfunction SyndromeNetherlands, Belgium
-
McGill UniversityInnodem NeurosciencesRecruitingClinically Isolated Syndrome | Relapsing Remitting Multiple SclerosisCanada
-
Hikma Pharmaceuticals LLCCompletedRelapsing Remitting Multiple SclerosisAlgeria, Egypt, Jordan
-
Regina Elena Cancer InstituteIcahn School of Medicine at Mount Sinai; University of Roma La SapienzaUnknownMultiple Sclerosis | RelapseUnited States, Italy
-
NovartisCompletedMultiple SclerosisUnited States, Korea, Republic of, Portugal, Canada, Hungary, Spain, Germany, United Kingdom, Australia, Argentina, Austria, Belgium, Brazil, Egypt, France, Greece, Italy, Switzerland
-
University of AarhusAarhus University Hospital; Regionshospitalet Viborg, Skive; Gødstrup Hospital; Sorbonne UniversityRecruitingRelapsing Remitting Multiple SclerosisDenmark
-
Contineum TherapeuticsRecruitingRelapsing Remitting Multiple SclerosisUnited States
-
Hoffmann-La RocheicometrixNot yet recruitingRelapsing Remitting Multiple Sclerosis